Atlas Trials

Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML

Clinical trial NCT02888522 · UNKNOWN

Trial details

NCT number
NCT02888522
Sponsor
University Hospital, Caen
Status
UNKNOWN
Study type
OBSERVATIONAL
AML
Start date
2016-06-01
Primary completion
2016-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.